Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Democratic senator calls on HHS to investigate PBMs blocking access to generic cancer drug

by
June 25, 2024
in Health Care
0
Democratic senator calls on HHS to investigate PBMs blocking access to generic cancer drug

Sen. Jacky Rosen (D-Nev.) wants the Department of Health and Human Services (HHS) to investigate why a low-cost generic cancer drug isn’t widely available to patients. 

In a letter sent to HHS Tuesday shared first with The Hill, Rosen questioned why Medicare patients pay $3,000 a month for abiraterone, a generic oral drug used as part of prostate cancer treatment, when a version that costs $171 is also on the market. 

The drug is sold by CivicaScript, a nonprofit that works with manufacturers to develop a drug and then partners with insurers, pharmacies and pharmacy benefit managers (PBMs) to sell it to patients at a fraction of the price it would cost otherwise. 

The cost of the drug from Civica is $160, with a suggested final price to the consumer of $171. But the drug is only available to a limited number of patients, according to Rosen and Civica.

Rosen asked HHS to investigate and identify the “market barriers” preventing widespread access to abiraterone, as well other low-cost drugs being blocked from patient access. 

Abiraterone is considered a “specialty drug,” meaning only specialty pharmacies can dispense it. Many PBMs run their own specialty pharmacies and earn money from dispensing expensive drugs, so there’s a financial incentive for them not to participate with Civica.  

Only one the three largest PBM-owned specialty pharmacies have purchased or dispensed Civica’s version of abiraterone, and only in small quantities, according to Civica. 

“A cancer diagnosis is already difficult enough for patients to navigate with the best of care, but it is unacceptable for an approved low-cost treatment to be limited to the point that patients cannot easily access the treatment or the benefit from the cost savings,” Rosen wrote.  

“Patients should now be seeing a drastic reduction in cost for abiraterone due to Civica’s lower price structure, and it is unacceptable that the cost for cancer patients to access this life-saving prescription drug has remained unreasonably high due to barriers preventing Civica’s drug from being widely available,” Rosen added. 

Previous Post

House Republican proposes barring defense funding for IVF, says it’s ‘morally wrong’ 

Next Post

WHO ignites calls for urgent action on a dangerous mpox strain

Next Post
WHO ignites calls for urgent action on a dangerous mpox strain

WHO ignites calls for urgent action on a dangerous mpox strain

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    FDA reinstates ousted top vaccine regulator Vinay Prasad

    FDA reinstates ousted top vaccine regulator Vinay Prasad

    August 9, 2025
    Abortion shield laws face mounting pressure

    Abortion shield laws face mounting pressure

    August 9, 2025
    CDC likely target in Atlanta shooting that killed officer

    CDC likely target in Atlanta shooting that killed officer

    August 9, 2025

    Trending

    Vance doesn’t say where patients will get care if Planned Parenthood is defunded

    Vance doesn’t say where patients will get care if Planned Parenthood is defunded

    October 13, 2024
    Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro

    Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro

    April 23, 2025
    Triplets are becoming less common in the United States. Here’s why

    Triplets are becoming less common in the United States. Here’s why

    November 6, 2024
    RFK Jr. pointedly attacks Trump over COVID response in Libertarian Party speech 

    RFK Jr. pointedly attacks Trump over COVID response in Libertarian Party speech 

    May 25, 2024

    Recent News

    FDA reinstates ousted top vaccine regulator Vinay Prasad

    FDA reinstates ousted top vaccine regulator Vinay Prasad

    August 9, 2025
    Abortion shield laws face mounting pressure

    Abortion shield laws face mounting pressure

    August 9, 2025

    Popular News

    • FDA reinstates ousted top vaccine regulator Vinay Prasad
    • Abortion shield laws face mounting pressure

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.